SCHEMBL6153333

SCHEMBL6153333

CC(C)(C)OC(=O)NC1CCC(Nc2ccc(C(N)=O)cc2)CC1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM1A O60341 1/20 0.47
MAOB P27338 1/20 0.47
NAMPT P43490 1/20 0.47
ALDH1A1 P00352 2/20 0.45
NPC1 O15118 1/20 0.44
MAPT P10636 1/20 0.44
MAPK1 P28482 1/20 0.44
HTT P42858 1/20 0.44
RAB9A P51151 1/20 0.44
L3MBTL1 Q9Y468 1/20 0.44
GPR119 Q8TDV5 1/20 0.44
DRD2 P14416 5/20 0.44
DRD3 P35462 1/20 0.43
BTK Q06187 5/20 0.43
EPHX2 P34913 2/20 0.42
FAAH O00519 1/20 0.42
NFKB1 P19838 1/20 0.42
NFKB2 Q00653 1/20 0.42
RELA Q04206 1/20 0.42
PARP1 P09874 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL594741 0.86 ALDH1A1 (0.52) KDM1AMAOBNAMPTALDH1A1NPC1
SCHEMBL1101802 0.86 ALDH1A1 (0.52) KDM1AMAOBNAMPTALDH1A1NPC1
SCHEMBL6154728 0.85 PTPN2 (0.49) KDM1AMAOBNAMPTNPC1RAB9A
SCHEMBL31205836 0.84 DRD2 (0.50) KDM1AMAOBNAMPTALDH1A1NPC1
SCHEMBL32665319 0.84 KDM1A (0.49) KDM1AMAOBNAMPTALDH1A1NPC1
SCHEMBL23720467 0.84 KDM1A (0.49) KDM1AMAOBNAMPTALDH1A1NPC1
SCHEMBL31205987 0.84 KDM1A (0.49) KDM1AMAOBNAMPTALDH1A1NPC1
SCHEMBL30556445 0.84 KDM1A (0.49) KDM1AMAOBNAMPTALDH1A1NPC1
SCHEMBL25039551 0.84 EPHX2 (0.50) KDM1AMAOBNAMPTALDH1A1NPC1
SCHEMBL18481691 0.83 KDM1A (0.61) KDM1AMAOBNAMPTALDH1A1NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050182040-A1 Benzamide derivatives DAINIPPON SUMITOMO PHARMA CO., LTD. (JP) 2005-08-18 US disclosed
EP-1500643-A1 BENZAMIDE DERIVATIVES SUMITOMO PHARMACEUTICALS COMPANY, LIMITED (JP) 2005-01-26 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050182040-A1 Benzamide derivatives ROCK1, ROCK2, NHERF1 KDM1A 728/4885MAOB 1169/4885NAMPT 1121/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.